Molecular network of obesity: What does it promise for pharmacotherapy?

Obesity Reviews

Volumn 9, Issue 3, 2008, Pages 236-245

  Myslobodsky, M ^a,b  

^a HOWARD UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Modularity; Networks; Neuropeptides; Polypharmacy

Indexed keywords

ADRENERGIC RECEPTOR; DOPAMINE RECEPTOR; GASTRIN; GHRELIN; HISTAMINE RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; OREXIN; SEROTONIN AGONIST;

APPETITE; BODY WEIGHT; EATING; NEUROPROTECTION; NONHUMAN; OBESITY; REVIEW;

EID: 42249101395     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2007.00424.x     Document Type: Review

References (82)

1. Kopelman PG. Clinical treatment of obesity: are drugs and surgery the answer? Proc Nutr Soc 2005 64 : 65 71.
2. Despres J-P, Golay A, Sjostrom L. for the Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005 353 : 2121 2134.
3. Astrup A, Greenway FL, Ling W, Pedicone L, Lachowicz J, Strader CD, Kwan R for the Ecopipam Obesity Study Group. Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects. Obesity 2007 15 : 1717 1731.
4. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry 2003 54 : 330 337.
5. Berkowitz RI, Fabricatore AN. Obesity, psychiatric status, and psychiatric medications. Psychiatr Clin North Am 2005 28 : 39 +.
6. Jandacek RJ, Woods SC. Pharmaceutical approaches to the treatment of obesity. Drug Discov Today 2004 15 : 874 880.
7. Chaput J-P, Tremblay A. Current and novel approaches to the drug therapy of obesity. Eur J Clin Pharmacol 2006 62 : 793 803.
8. Watts DJ, Strogatz SH. Collective dynamics of 'small-world' networks. Nature 1999 393 : 440 442.
9. Watts DJ. Small Worlds. The Dynamics of Networks Between Order and Randomness. Princeton University Press, Princeton, 1999.
10. Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. Network motifs: simple building blocks of complex networks. Science 2002 298 : 824 827.
11. Bales ME, Johnson SB. Graph theoretic modeling of large-scale semantic networks. J Biomed Inform 2006 39 : 451 464.
12. Borrett SR, Fath BD, Patten BC. Functional integration of ecological networks through pathway proliferation. J Theor Biol 2007 245 : 98 111.
13. Bray GA. Afferent signals regulating food intake. Proc Nutr Soc 2000 59 : 676 677.
14. Chaudhri O, Small C, Bloom S. Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci 2006 361 : 1187 1209.
15. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007 132 : 2116 2130.
16. Dhillo WS. Appetite regulation: an overview. Thyroid 2007 17 : 433 445.
17. Almaas E. Biological impacts and context of network theory. J Exp Biol 2007 210 : 1548 1558.
18. Zhao J, Yu H, Luo J-H, Cao Z-W, Li Y-X. Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics 2006 7 : 386.
19. Böde C, Kovacs IA, Szalay MS, Palotai R, Korcsmáros T, Csermely P. Network analysis of protein dynamics. FEBS Lett 2007 581 : 2776 2782.
20. Spornsa O, Chialvob DR, Kaiserc M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn Sci 2004 8 : 418 425.
21. Bassett DS, Bullmore E. Small-world brain networks. Neuroscientist 2006 12 : 512 523.
22. Delahanty LM, Meigs JB, Hayden D, Williamson DA, Nathan DM. Psychological and behavioral correlates of baseline BMI in the diabetes prevention program (DPP). Diabetes Care 2002 25 : 1992 1998.
23. Cummings DE, Foster-Schubert KE, Overduin J. Ghrelin and energy balance: focus on current controversies. Curr Drug Targets 2005 6 : 153 169.
24. Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005 30 : 1187 1192.
25. Berridge K, Robinson T. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998 28 : 309 369.
26. Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 2007 12 : 6 16.
27. Carlini V, Schiöth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 2007 352 : 907 912.
28. Beach FA. Characteristics of masculine 'sex drive'. Nebr Symp Motiv 1956 4 : 1 32.
29. Johnstone LE, Fong TM, Leng G. Neuronal activation in the hypothalamus and brainstem during feeding in rats. Cell Metab 2006 4 : 313 321.
30. Diano S, Farr SA, Benoit SC, Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath, TL. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006 381 388.
31. Szentirmai E. Kapás L, Krueger, J.M. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 2007 292 : R575 R585.
32. Yannielli PC, Molyneux PC, Harrington ME, Golombek DA. Ghrelin effects on the circadian system of mice. J Neurosci 2007 27 : 2890 2895.
33. Barbano MF, Stinus L, Cador M, Ahmed SH. Mesolimbic dopamine drives the diurnal variation in opiate-induced feeding. Pharmacol Biochem Behav 2005 81 : 569 574.
34. Kallingal GJ, Mintz EM. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase. Neurosci Lett 2007 422 : 59 63.
35. Stutz AM, Staszkiewicz J, Ptitsyn A, Argyropoulos G. Circadian expression of genes regulating food intake. Obesity 2007 15 : 607 615.
36. Kelley AE, Baldo BA, Pratt WE. A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward. J Comp Neurol 2005 493 : 72 85.
37. Hamet P, Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metabolism 2006 55 : S7 S12.
38. Rodgers RJ, Ishii Y, Halford JC, Blundell JE. Orexins and appetite regulation. Neuropeptides 2002 36 : 303 325.
39. Kotz CM. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 2006 88 : 294 301.
40. Karl A, Schaefer M, Malta LS, Dorfel D, Rohleder N, Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neuroscience and Biobehavioral Reviews 2006 30 : 1004 1031.
41. Valenstein ES, Cox VC, Kakolewski JW. Reexamination of the role of the hypothalamus in motivation. Psychol Rev 1970 77 : 16 31.
42. Valenstein ES. Channelling of responses elicited by hypothalamic stimulation. J Psychiatr Res 1971 8 : 335 344.
43. Henson M, Castracane V. Leptin in pregnancy. Biol Reprod 2000 63 : 1219 1228.
44. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2006 290 : R894 R903.
45. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006 51 : 811 822.
46. Harvey J. Leptin: a multifaceted hormone in the central nervous system. Mol Neurobiol 2003 28 : 245 258.
47. Harvey J, Shanley LJ, O'Malley D, Irving AJ. Leptin: a potential cognitive enhancer? Biochem Soc Trans 2005 33 : 1029 1032.
48. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003 9 : 1173 1179.
49. Takenaka Y, Nakamura F, Jinsmaa Y, Lipkowski AW, Yoshikawa M. Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities. Biosci Biotechnol Biochem 2001 65 : 236 238.
50. Voisey J, Van Daal A. Agouti: from mouse to man, from skin to fat. Pigment Cell Res 2002 15 : 10 18.
51. Nordin C, Sjödin I. CSF cholecystokinin, γ-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls. J Neural Transm 2007 114 : 499 503.
52. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007 147 : 260 271.
53. Roesler R, Henriques J, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. CNS Neurol Disord Drug Targets 2006 5 : 197 204.
54. Yamada K, Santo-Yamada Y, Wada E, Wada K. Role of bombesin (BN) -like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice. Mol Psychiatry 2002 7 : 113 117.
55. Fisher LA, Cave CR, Brown MR. Central nervous system cardiovascular effects of bombesin in conscious rats. Am J Physiol 1985 248 : H425 H431.
56. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 1998 18 : 4758 4766.
57. Merali Z, Khan S, Michaud DS, Shippy SA, Anisman H. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release. Eur J Neurosci 2004 20 : 229 239.
58. Brighton PJ, Szekeres PG, Willars GB. Neuromedin U and its receptors. structure, function, and physiological roles. Pharmacol Rev 2004 56 : 231 248.
59. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006 7 : 678 689.
60. Pan D. Hippo signaling in organ size control. Genes Dev 2007 21 : 886 897.
61. Sih A, Bell AM, Johnson JC, Ziemba RE. Behavioral syndromes: an intergrative overiew. Q Rev Biol 2004 79 : 241 277.
62. Kalsbeek A, Fliers E, Hofman MA, Swaab DF, van Someren EJW, Buijs RM. What Can We Learn From Seasonal Animals about the Regulation of Energy Balance? Hypothalamic Integration of Energy Metabolism. Proceedings of the 24th International Summer School of Brain Research, Held at the Royal Netherlands Academy of Arts and Sciences. Elsevier: Amsterdam, 1995, 325 337.
63. Bell AM. Future directions in behavioural syndromes research. Proc Biol Sci 2007 274 : 755 761.
64. Wagner GP. Homologues, natural kinds and the evolution of modularity. Am Zool 1996 36 : 36 43.
65. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999 402 : C47 C52.
66. Raff RA, Sly BJ. Modularity and dissociation in the evolution of gene expression territories in development. Evol Dev 2000 2 : 102 113.
67. Szyf M, Weaver I, Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 2007 24 : 9 19.
68. Rüedi-Bettschen D, Pedersen E, Feldon J, Pryce C.R. Early deprivation under specific conditions leads to reduced interest in reward in adulthood in Wistar rats. Behav Brain Res 2005 156 : 297 310.
69. Mathé A, Husum H, Khoury AE, Jiménez-Vasquez P, Gruber SH, Wörtwein G, Nikisch G, Baumann P, Agren H, Andersson W, Södergren A, Angelucci F. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol Behav 2007 92 : 226 231.
70. Broberger C. Brain regulation of food intake and appetite. molecules and networks. J Intern Med 2005 258 : 301 327.
71. Newman MEJ. The structure and function of complex networks. SIAM Rev 2003 45 : 167 256.
72. Blundell JE. Perspective on the central control of appetite. Obesity (Silver Spring) 2006 14 (Suppl. 4 160S 163S.
73. Ostwald D, Karpac J, Hochgeschwender U. Effects on hippocampus of lifelong absence of glucocorticoids in the pro-opiomelanocortin null mutant mouse reveal complex relationship between glucocorticoids and hippocampal structure and function. J Mol Neurosci 2006 28 : 291 302.
74. Pillsworth EG, Haselton MG, Buss DM. Ovulatory shifts in female sexual desire. J Sex Res 2004 41 : 55 65.
75. Berger K, Winzell MS, Mei J, Erlanson-Albertsson C. Enterostatin and its target mechanisms during regulation of fat intake. Physiol Behav 2004 83 : 623 630.
76. Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci 2006 31 : 303 314.
77. Myslobodsky M, Weiner I. Contemporary Issues in Modeling Psychopathology. Kluwer Academic : Boston, MA, 2000.
78. Kaiser M, Martin R, Andras P, Young MP. Simulation of robustness against lesions of cortical networks. Eur J Neurosci 2007 25 : 3185 3192.
79. Wasan KM, Looije N. Emerging pharmacological approaches to the treatment of obesity. J Pharm Pharm Sci 2005 8 : 259 271.
80. Painter RC, de Rooij SR, Bossuyt PM, Painter RC, de Rooij SR, Bossuyt PM, Simmers TA, Osmond C, Barker DJ, Bleker OP, Roseboom TJ. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr 2006 84 : 322 327.
81. Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005 54 : 1638 1649.
82. Michel MC, Alewijnse AE. Ligand-Directed Signaling: 50 Ways to Find a Lover. Mol Pharmacol 2007 72 : 1097 1099.